List of Tables
Table 1. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Value Comparison by Sales Channel (2024-2030) & (US$ Million)
Table 3. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit) by Type (2019-2024)
Table 59. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit) by Type (2025-2030)
Table 60. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Sales Channel (2019-2024)
Table 61. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Sales Channel (2025-2030)
Table 62. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2019-2024)
Table 63. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Sales Channel (2025-2030)
Table 64. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$ Million) by Sales Channel (2019-2024)
Table 65. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$ Million) by Sales Channel (2025-2030)
Table 66. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Sales Channel (2019-2024)
Table 67. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Sales Channel (2025-2030)
Table 68. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit) by Sales Channel (2019-2024)
Table 69. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit) by Sales Channel (2025-2030)
Table 70. Bausch Health Corporation Information
Table 71. Bausch Health Description and Business Overview
Table 72. Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product
Table 74. Bausch Health Recent Developments/Updates
Table 75. Allergan Corporation Information
Table 76. Allergan Description and Business Overview
Table 77. Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product
Table 79. Allergan Recent Developments/Updates
Table 80. Sebela Pharmaceuticals Corporation Information
Table 81. Sebela Pharmaceuticals Description and Business Overview
Table 82. Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product
Table 84. Sebela Pharmaceuticals Recent Developments/Updates
Table 85. Astellas Pharmaceuticals Corporation Information
Table 86. Astellas Pharmaceuticals Description and Business Overview
Table 87. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product
Table 89. Astellas Pharmaceuticals Recent Developments/Updates
Table 90. Amneal Pharms Corporation Information
Table 91. Amneal Pharms Description and Business Overview
Table 92. Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product
Table 94. Amneal Pharms Recent Developments/Updates
Table 95. Pharscin Pharma Corporation Information
Table 96. Pharscin Pharma Description and Business Overview
Table 97. Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product
Table 99. Pharscin Pharma Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors List
Table 103. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Customers List
Table 104. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Trends
Table 105. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Drivers
Table 106. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Challenges
Table 107. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
Figure 2. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type in 2023 & 2030
Figure 4. XIFAXAN Product Picture
Figure 5. Viberzi Product Picture
Figure 6. Lotronex Product Picture
Figure 7. Other Product Picture
Figure 8. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Value Comparison by Sales Channel (2024-2030) & (US$ Million)
Figure 9. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Sales Channel in 2023 & 2030
Figure 10. Hospitals Pharmacy
Figure 11. Retail Pharmacy
Figure 12. Other
Figure 13. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (2019-2030) & (US$ Million)
Figure 15. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (2019-2030) & (K Units)
Figure 16. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price (USD/Unit) & (2019-2030)
Figure 17. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Report Years Considered
Figure 18. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Manufacturers in 2023
Figure 19. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players: Market Share by Revenue in 2023
Figure 21. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country (2019-2030)
Figure 24. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country (2019-2030)
Figure 28. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country (2019-2030)
Figure 29. Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Region (2019-2030)
Figure 36. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country (2019-2030)
Figure 46. Latin America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type (2019-2030)
Figure 56. Global Revenue Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type (2019-2030)
Figure 57. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Sales Channel (2019-2030)
Figure 59. Global Revenue Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Sales Channel (2019-2030)
Figure 60. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit) by Sales Channel (2019-2030)
Figure 61. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Value Chain
Figure 62. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed